Insider trade

United Therapeutics (UTHR): Director exercised options on 650 shares

Jan Malcolm, Director at United Therapeutics, reported an option exercise of 650 shares.

650
Shares
Traded
Jul 9, 2026
Filed
Jul 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 7, 2026Insider · 2 peopleInsiders: 37 sales (~$11.3M)
  2. May 8, 2026Insider · 1 personInsiders: 10 sales (~$5.4M)
  3. May 11, 2026Insider · 2 peopleInsiders: 24 sales (~$11.2M)
  4. May 12, 2026Insider · 1 personInsiders: 9 sales (~$2.8M)
  5. Jun 26, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“As described in Item 5.07 below, on June 26, 2026, at the 2026 Annual Meeting of Shareholders of United Therapeutics Corporation (the Company ), the Company’s shareholders approved the United Therapeutics Corporation 2026 Stock Incentive Plan (the 2026 Plan ).”

What came next

  1. Jul 22, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 22, 2026, the Board of Directors (the Board ) of United Therapeutics Corporation (the Company ), acting upon the recommendation of its Nominating and Governance Committee, increased the size of the Board to 13 members and appointed Victor Dzau, M.D., to serve as a member of the Board.”
  2. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
  3. Sep 8, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
  4. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results
  5. Nov 4, 20265% stakeMartine A. Rothblatt reported a passive stake (13G) of 4.0%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for United Therapeutics

For United Therapeutics, OQRO holds 890 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its UTHR page.

Other recent filings by Jan Malcolm, Director

The full history of Jan Malcolm, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which United Therapeutics (UTHR) insider traded, and how much?

Jan Malcolm, Director at United Therapeutics, reported an option exercise of 650 shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Jul 9, 2026. Filed: Jul 11, 2026. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about United Therapeutics recently?

For United Therapeutics, OQRO holds 890 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the UTHR page.

Does this mean UTHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at United Therapeutics

Everything OQRO holds on this company is on its UTHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data